Register for free to listen to this article
Listen with Speechify
0:00
1:00
GERMANTOWN, Md.—QIAGEN announced May 3 that it has joinedthe Point-of-Care Diagnostics (POC Dx) Initiative led by the Bill & MelindaGates Foundation and Grand Challenges Canada to create a new moleculardiagnostics platform to serve resource-poor regions of the world.
 
 
QIAGEN is joining more than 20 nonprofit, academic andcorporate organizations in the POC Dx Initiative, which aims to catalyze a"diagnostics revolution" for the developing world. The goal of the initiativeis to create new platforms that enable high-quality, low-cost point-of-carediagnosis, and to make systematic and sustainable improvements in healthcare inthe developing world.
 
 
In a press release announcing its participation, QIAGENnoted that the development of affordable and portable diagnostic systems is oneof the 16 Grand Challenges in Global Health, an initiative that seeks toenhance healthcare in the world's poorest countries, and the company hasalready started the development of a portable instrument based on its advancedmolecular testing technologies for point-of-need applications.
 
 
QIAGEN's role in the initiative is to develop aneasy-to-use, portable molecular testing device that can perform diagnostictests in the field, far from hospital or laboratory infrastructure. This taskalso encompasses the creation of a corresponding assay technology suited foruse in low-resource settings. This project is part of the technologydevelopment phase of the POC Dx initiative, which will then integratesuccessful technologies into a multifunctional point-of-care platform.
 
 
"The new low-cost portable testing devices currently underdevelopment are intended to enable reliable, quick diagnosis and timeliertreatment of patients," said Dr. Ellen Sheets, chief medical officer of QIAGEN,in a statement. "We believe that modern diagnostic technologies can have a verysignificant positive impact on developing countries, helping to save lives,reduce economic impacts, and curtail the spread of infectious diseases."

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A doctor wearing blue gloves and a white lab coat with a stethoscope around their neck holds a rendering of a digestive system on a glass pane with a swirled blue background.

Connecting the gut and liver to enhance drug development

Explore how a dual-organ microphysiological system connects human gut and liver tissue to bridge gaps in predicting how drugs behave in the body.
A syringe draws liquid from a glass vial, with several glass ampoules reflected on a glossy surface in the background

Turning up the heat: thermal analysis for biotherapeutics

Explore essential thermal stability techniques to ensure the safety, quality, and efficacy of biologic drugs.
A 3D-rendered image of a pink and white twisted RNA strand floating against a green, blurred cellular background.

Cutting the time and cost out of plasmid generation

Discover a hassle-free path to obtaining long, complex plasmid DNA.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue